921.7000 -16.80 (-1.79%)
NSE Feb 27, 2026 15:31 PM
Volume: 1.0M
 

921.70
-1.79%
Phillip Capital
growth was +6% yoy (vs estimated 8%). EBITDA margin at 21.9% was 120bps below our estimates of 23.1%. The PAT (adjusted forforex gain ofRs448mn) declined 14% yoyto Rs 3.21bn(implying20%/17%misstoour/consensusestimates).InQ1FY17,CDHhasremoved JVsalesfromconsolidatedsalesandbookedtheshareofprofitfromJVsasperINDAS.Ifwe...
Zydus Lifesciences Ltd. is trading above its 50 day SMA of 903.4
More from Zydus Lifesciences Ltd.
Recommended